Testing effectiveness (Phase 2)WithdrawnNCT02143050What this trial is testingStudy of Dabrafenib, Trametinib and Metformin for Melanoma PatientsWho this might be right forMelanoma University of Louisville
Early research (Phase 1)UnknownNCT03086174What this trial is testingTolerability and Pharmacokinetics of Toripalimab in Combination With Axitinib in Patients With Kidney Cancer and MelanomaWho this might be right forKidney Cancer Stage IvAdvanced Melanoma Shanghai Junshi Bioscience Co., Ltd. 24
Early research (Phase 1)Study completedNCT02166255What this trial is testingAPN401 in Treating Patients With Melanoma, Kidney Cancer, Pancreatic Cancer, or Other Solid Tumors That Are Metastatic or Cannot Be Removed By SurgeryWho this might be right forRecurrent MelanomaRecurrent Pancreatic CancerRecurrent Renal Cell Cancer+9 more Wake Forest University Health Sciences 17
Early research (Phase 1)Study completedNCT02659540What this trial is testingPilot Study of the Safety/Efficacy of Combination Checkpoint Blockade + External Beam Radiotherapy in Stage IV MelanomaWho this might be right forMelanoma Ludwig Institute for Cancer Research 20
Early research (Phase 1)Study completedNCT00729950What this trial is testingStudy of MDX-010 in Subjects With Unresectable Stage III or Stage IV Malignant MelanomaWho this might be right forMalignant Melanoma Bristol-Myers Squibb 92
Testing effectiveness (Phase 2)Looking for participantsNCT05296564What this trial is testingAnti-NY-ESO-1 TCR-Gene Engineered Lymphocytes Given by Infusion to Patients With NY-ESO-1 -Expressing Metastatic CancersWho this might be right forSarcoma, SynovialSarcoma,Soft TissueMelanoma Stage IV+6 more Hadassah Medical Organization 3
Testing effectiveness (Phase 2)Active Not RecruitingNCT05180799What this trial is testingBA3071 in Patients With Solid TumorsWho this might be right forNSCLCMelanoma BioAtla, Inc. 320
Early research (Phase 1)Active Not RecruitingNCT03816332What this trial is testingTacrolimus, Nivolumab, and Ipilimumab in Treating Kidney Transplant Recipients With Selected Unresectable or Metastatic CancersWho this might be right forClinical Stage III Cutaneous Melanoma AJCC v8Clinical Stage III Cutaneous Merkel Cell Carcinoma AJCC v8Clinical Stage IV Cutaneous Melanoma AJCC v8+18 more National Cancer Institute (NCI) 12
Testing effectiveness (Phase 2)Study completedNCT00036764What this trial is testingBMS-247550 in Treating Patients With Stage IV MelanomaWho this might be right forRecurrent MelanomaStage IV Melanoma National Cancer Institute (NCI) 88
Not applicableActive Not RecruitingNCT04990726What this trial is testingImmune Related Toxicity and Symptom Burden in Chronic Cancer Survivors With Melanoma Receiving Adjuvant Immunotherapy With Immune Checkpoint InhibitorsWho this might be right forClinical Stage III Cutaneous Melanoma AJCC v8Pathologic Stage III Cutaneous Melanoma AJCC v8Pathologic Stage IIIA Cutaneous Melanoma AJCC v8+5 more M.D. Anderson Cancer Center 126
Testing effectiveness (Phase 2)Study completedNCT00568048What this trial is testingTemozolomide and Bevacizumab in Treating Patients With Stage IV Melanoma That Cannot Be Removed By SurgeryWho this might be right forMelanoma (Skin) Swiss Cancer Institute 62
Testing effectiveness (Phase 2)UnknownNCT01676649What this trial is testingIpilimumab With Carboplatin and Paclitaxel in Patients With Unresectable Stage III and Stage IV MelanomaWho this might be right forUntreated Stage III Melanoma or Stage IV Melanoma Jewish General Hospital 30
Early research (Phase 1)Study completedNCT00390338What this trial is testingVaccine Therapy in Treating Patients With Stage III or Stage IV MelanomaWho this might be right forMelanoma (Skin) Pawel Kalinski 22
Early research (Phase 1)WithdrawnNCT00006126What this trial is testingPeripheral Stem Cell Transplantation in Treating Patients With Melanoma or Small Cell Lung, Breast, Testicular, or Kidney Cancer That is Metastatic or That Cannot Be Treated With SurgeryWho this might be right forBreast CancerKidney CancerLung Cancer+2 more Northwestern University
Testing effectiveness (Phase 2)Ended earlyNCT01166126What this trial is testingTemsirolimus/AZD 6244 for Treatment-naive With BRAF Mutant Unresectable Stage IVWho this might be right forMucosal MelanomaRecurrent MelanomaStage IV Melanoma National Cancer Institute (NCI) 4
Not applicableStudy completedNCT03553329What this trial is testingStudy of the Variations of Albumin Level for Patients With Unresecable Stage IIIc or Stage IV Melanoma Treated by Anti BRAF and Anti MEKWho this might be right forUnresecable Stage IIIc or IV Melanoma Poitiers University Hospital 20
Early research (Phase 1)UnknownNCT03353402What this trial is testingFecal Microbiota Transplantation (FMT) in Metastatic Melanoma Patients Who Failed ImmunotherapyWho this might be right forMelanoma Stage IvUnresectable Stage III Melanoma Sheba Medical Center 40
Testing effectiveness (Phase 2)Study completedNCT00436605What this trial is testingDasatinib in Treating Patients With Stage III Melanoma That Cannot Be Removed By Surgery or Stage IV MelanomaWho this might be right forRecurrent MelanomaStage IIIA MelanomaStage IIIB Melanoma+2 more National Cancer Institute (NCI) 39
Early research (Phase 1)UnknownNCT00037037What this trial is testingVaccine Therapy With or Without Sargramostim in Treating Patients With High-Risk or Metastatic MelanomaWho this might be right forMelanoma (Skin) Herbert Irving Comprehensive Cancer Center
Testing effectiveness (Phase 2)Ended earlyNCT01970527What this trial is testingPhase II Trial of Stereotactic Body Radiotherapy Followed by Ipilimumab in Treating Patients With Stage IV MelanomaWho this might be right forRecurrent MelanomaStage IV Skin Melanoma University of Washington 23